Amin Afrasiabi, MD, Pediatric Urologist
Pediatric Urology Academy
Pediatric Urology Academy is an evidence-based educational podcast hosted by Amin Afrasiabi, MD, Pediatric Urologist. Each episode explores pediatric urology through clinical cases, landmark studies, practical decision-making, surgical principles, and emerging research. Topics include posterior urethral valves, vesicoureteral reflux, hydronephrosis, UPJO, megaureter, neurogenic bladder, hypospadias, disorders of sexual development, pediatric stone disease, and reconstructive surgery. Designed for pediatric urologists, urologists, residents, fellows, and healthcare professionals worldwide.
Be sure to visit the podcast's website and support the creator: podcasters.spotify.com
Author
Amin Afrasiabi, MD, Pediatric Urologist
Category
Podcast website
Latest episode
Nov 20, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Nephrogenic Rests and Nephroblastomatosis: Chemotherapy Before Cancer 20.11.2026 10:24
What if we could treat the precursor of Wilms tumor before a malignancy develops? Diffuse hyperplastic perilobar nephroblastomatosis presents an unusual dilemma in pediatric renal oncology: administering chemotherapy to preserve kidneys and reduce the risk of future cancer, even when a malignant tumor has not been established. In this episode of Pediatric Urology Academy, Amin Afrasiabi, MD, exami...
Congenital Mesoblastic Nephroma: When Aggressive Histology Predicts a Favorable Outcome 19.11.2026 8:50
A renal mass is detected before birth. Histology reveals a highly cellular tumor with frequent mitoses, resembling an aggressive sarcoma. Yet the molecular findings may predict a favorable outcome. In this episode of Pediatric Urology Academy, Amin Afrasiabi, MD, examines the counterintuitive biology of congenital mesoblastic nephroma, one of the characteristic renal tumors of early infancy. We ex...
Clear Cell Sarcoma of the Kidney: The Flank Is Not the Failure Site 18.11.2026 9:29
In clear cell sarcoma of the kidney, the most important site of relapse may not be where the surgeon operated. It may be the brain. For decades, even stage I clear cell sarcoma was routinely treated with postoperative radiotherapy. Then the Children's Oncology Group investigated whether flank radiation could be omitted in carefully staged patients. Seven children with stage I disease received...
The Renal Mass That Is Not Wilms: What It Costs to Be Wrong 17.11.2026 10:20
A three-year-old presents with a solid renal mass. Imaging strongly suggests Wilms tumor. But what happens when the diagnosis is wrong? Not every pediatric renal malignancy behaves like Wilms tumor. Rhabdoid tumor, renal cell carcinoma, renal medullary carcinoma, and congenital mesoblastic nephroma differ in their molecular biology, treatment sensitivity, prognosis, and surgical implications. In t...
Pediatric Cystic Nephroma: The Benign Tumor That Changes a Family’s Future 16.11.2026 10:08
A two-year-old has a multilocular cystic renal tumor. Pathology confirms cystic nephroma. The lesion is benign, and surgery may be curative. But the diagnosis raises questions extending far beyond the kidney. In this episode of Pediatric Urology Academy, Amin Afrasiabi, MD, explores three uncertainties that shape the management of pediatric cystic nephroma: • What is hidden within the cystic septa...
Paratesticular Rhabdomyosarcoma: The Age-10 Rule 15.11.2026 10:00
A 12-year-old boy has paratesticular rhabdomyosarcoma. His staging CT shows no enlarged retroperitoneal lymph nodes. Can we trust the scan? In a Children's Oncology Group analysis of 279 patients, imaging missed more than half of pathologically involved nodes in older children. This finding helps explain one of pediatric oncologic surgery's most consequential age-based recommendations: sur...
Bladder and Prostate Rhabdomyosarcoma: Preservation Is Not Function 14.11.2026 10:20
We saved the bladder. But did we preserve its function? In a landmark analysis of 88 children with bladder and prostate rhabdomyosarcoma, only 36 were reported to be alive, event-free, and have normal bladder function. Even that assessment relied primarily on clinical history rather than objective functional testing. In this episode of Pediatric Urology Academy, Amin Afrasiabi, MD, challenges one...
Prepubertal Testicular Tumors: When Preservation Replaces Orchiectomy 13.11.2026 11:26
For decades, yolk sac tumor was considered the most common testicular tumor in prepubertal boys. Then multicenter pathology data revealed a different picture: most prepubertal testicular tumors are benign. How did an incomplete picture of tumor biology influence generations of surgical decisions? In this episode of Pediatric Urology Academy, Amin Afrasiabi, MD, examines the shift from routine radi...
Relapsed Wilms Tumor: When Does Surgery Change Survival? 12.11.2026 10:08
Children who undergo surgery for relapsed Wilms tumor appear to survive longer. But does surgery improve survival, or are children with more favorable relapses simply more likely to undergo surgery? In this episode of Pediatric Urology Academy, Amin Afrasiabi, MD, examines one of the most difficult questions in pediatric oncology: when does an operation genuinely improve the outcome of salvage tre...
Wilms Tumor Predisposition: The Decision Before the First Nephrectomy 11.11.2026 9:36
What if the most important nephron-sparing decision happens before a child develops Wilms tumor? A one-year-old with atypical genitalia, a 46,XY karyotype, and proteinuria presents with normal-appearing kidneys. Yet this combination may signal a WT1-related disorder, with implications for both future malignancy and progressive renal disease. In this episode of Pediatric Urology Academy, Amin Afras...
Minimally Invasive Nephrectomy for Wilms Tumor: Can the Stage Be Trusted? 10.11.2026 11:32
Twenty-four children underwent minimally invasive nephrectomy for Wilms tumor. No tumor ruptured, every child was alive at follow-up, and twenty-three of twenty-four remained event-free. Adequate lymph-node sampling was reported in only two. This episode asks what it means for a Wilms operation to succeed. A Wilms nephrectomy has two products: a tumor removed safely, and a stage the oncology team...
Partial Nephrectomy for Unilateral Wilms Tumor: What Is a Nephron Worth? 09.11.2026 11:04
Partial nephrectomy for unilateral Wilms tumor is one of the most debated operations in pediatric surgical oncology — and one of the rarest. When the opposite kidney is normal, what does preserving a remnant actually buy, and what might it cost? This episode treats unilateral nephron-sparing surgery as an exchange: renal tissue gained against added complexity in tumor clearance, staging, and recon...
Bilateral Wilms Tumor: When Waiting Stops Saving Nephrons 08.11.2026 10:42
In bilateral Wilms tumor, chemotherapy can make nephron-sparing surgery possible. But when does continued treatment stop improving surgical options and start delaying definitive care? This episode of Pediatric Urology Academy examines the twelve-week surgical decision through three competing clocks: tumor response, histological information, and long-term renal reserve. Using evidence from the Chil...
Wilms Tumor in the Vena Cava: When Chemotherapy Is the Safer Operation 27.10.2026 10:13
A Wilms tumor extending into the inferior vena cava can look like a surgical emergency. Sometimes the safer oncologic decision is to wait. This episode examines venous tumor thrombus in Wilms tumor and asks when preoperative chemotherapy should be viewed not only as cancer treatment, but as surgical risk reduction. We explore renal-vein, infrahepatic, retrohepatic, suprahepatic, and atrial extensi...
The Lung Nodules That Decide Radiation 26.10.2026 10:53
A few millimeters on chest CT can change the entire treatment pathway for a child with Wilms tumor. This episode examines the uncertainty behind pulmonary nodules: which lesions are truly metastatic, what chemotherapy response actually tells us, when persistent nodules still contain viable tumor, and when biopsy or metastasectomy can meaningfully change management. We explore the response-adapted...
AREN2231: When Tumor Biology Starts Writing the Postoperative Prescription 25.10.2026 8:52
Wilms tumor treatment was once organized primarily around stage. AREN2231 is testing a more complex model. This episode examines how the Children’s Oncology Group is integrating anatomic stage with molecular biology and treatment response to determine who may need less therapy, who may need different therapy, and who may require intensification. We explore 1q gain, combined loss of heterozygosity...
One Tear Can Rewrite the Protocol 24.10.2026 10:53
A Wilms tumor can be completely removed and still become a stage III problem. This episode examines the events that can change local staging despite apparently successful surgery: tumor spill, preoperative rupture, biopsy, and positive margins. We explore why these events are not biologically equivalent, how COG and SIOP may interpret them differently, why imaging alone can misclassify rupture, an...
The Normal-Looking Node That Changes Treatment 23.10.2026 6:26
In Wilms tumor surgery, lymph-node sampling is not a technical afterthought. It is part of the staging operation. This episode examines why normal-looking nodes can still contain tumor, why suspicious nodes can be reactive, and why the purpose of sampling is not therapeutic lymphadenectomy but reduction of staging uncertainty. We also examine the evidence behind node counts, why detection studies...
COG vs SIOP: Why Two Successful Wilms Strategies Start in Opposite Directions 22.10.2026 11:12
Why does one major Wilms tumor system begin with nephrectomy while another begins with chemotherapy? This episode examines the deeper logic behind the COG and SIOP approaches. The real difference is not simply surgery first versus chemotherapy first. It is about which information each system chooses to preserve, and which uncertainty it accepts. We explore untreated staging, response biology, stag...
Season 6, Episode 20 — The Contradiction Map: Diagnose Biology Before Naming the Syndrome 20.10.2026 10:32
A 46,XY child can have a uterus. A 46,XX child can have virilized external genitalia. One patient can have two gonads that followed completely different developmental paths. These findings seem contradictory only if we expect every layer of sex development to agree. In this season finale of Pediatric Urology Academy, we build a reusable diagnostic framework for DSD: the Contradiction Map. Instead...
Season 6, Episode 19 — The Dysgenetic Gonad: Germ Cells, Fertility and Tumor Risk 19.10.2026 10:21
A dysgenetic gonad can contain hormonal function, potentially valuable germ cells, and oncologic risk at the same time. That is why the real question is not simply whether the gonad should stay or go. It is what biological value remains inside it—and what risk comes with preserving it. In this episode of Pediatric Urology Academy, we examine the dysgenetic gonad as three separate biological proble...
Season 6, Episode 18 — Mini-Puberty: Nature’s Dynamic Test of the DSD Pathway 18.10.2026 10:09
A newborn with a difference of sex development gives us anatomy. For a few months after birth, the endocrine system gives us something more valuable: function. Mini-puberty is a brief reactivation of the hypothalamic-pituitary-gonadal axis. During this window, LH and FSH rise, Leydig cells produce testosterone, Sertoli cells produce inhibin B and AMH, and the entire DSD pathway can be tested in re...
Season 6, Episode 17 — 46,XX Virilization: Follow the Androgen Backward 17.10.2026 10:14
A virilized 46,XX newborn with a uterus is not primarily a problem of testicular differentiation. It is a problem of prenatal androgen exposure. In this episode of Pediatric Urology Academy, we work backward from the phenotype to reconstruct where the androgen came from, when exposure occurred, and which steroidogenic pathway produced it. We explore: • why a uterus strongly shifts the diagnosis to...
Season 6, Episode 16 — 46,XX Testicular DSD: Building a Testis Without the Usual Y Chromosome 16.10.2026 11:08
A child can have a 46,XX karyotype and still develop testes. That is only paradoxical if we assume the Y chromosome itself builds the testis. It does not. The Y chromosome usually provides the trigger. The testis is built by the downstream gonadal-determination network. In this episode of Pediatric Urology Academy, we examine 46,XX testicular DSD as a disorder of gonadal determination rather than...
Season 6, Episode 15 — Ovotesticular DSD: When Ovarian and Testicular Programs Coexist 15.10.2026 10:35
A child can have ovarian follicles in one part of a gonad and seminiferous tubules in another. That is not developmental confusion. It is evidence that ovarian and testicular programs can coexist within the same individual—and sometimes within the same gonad. In this episode of Pediatric Urology Academy, we examine ovotesticular DSD as a problem of competing developmental networks rather than inco...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.